Skip to search.
 FTSE 100 Up 0.26%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
11.39 0.00(0.00%) 22 May 21:00
Add to Portfolio
Prev Close:11.39
Open:11.36
Bid:N/A
Ask:13.34 x 200
1y Target Est:16.00
Beta:2.14
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:11.31 - 11.57
52wk Range:2.15 - 13.20
Volume:616,907
Avg Vol (3m):1,802,480
Market Cap:1.10b
P/E (ttm):N/A
EPS (ttm):-0.93
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLD 0.00%1.10b
SHPGUp 0.74%51.08b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):889.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.10
Quarterly EPS Est (Jun-15) :-0.26
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback